Exploration on the Current Situation of Drug Regulation in China Since the Implementation of Marketing Authorization Holder System

Xu Dali, Zhang Wenxia

Chinese Pharmaceutical Affairs ›› 2023, Vol. 37 ›› Issue (8) : 857-863.

Chinese Pharmaceutical Affairs ›› 2023, Vol. 37 ›› Issue (8) : 857-863. DOI: 10.16153/j.1002-7777.2023.08.001
Supervision Administration

Exploration on the Current Situation of Drug Regulation in China Since the Implementation of Marketing Authorization Holder System

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2023, 37(8): 857-863 https://doi.org/10.16153/j.1002-7777.2023.08.001

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail

Sections
Recommended

/